KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $473,000 | +392.7% | 66,700 | +324.8% | 0.01% | +400.0% |
| Q1 2017 | $96,000 | -92.9% | 15,700 | -93.2% | 0.00% | -97.1% |
| Q4 2016 | $1,345,000 | +287.6% | 229,600 | +208.2% | 0.03% | +100.0% |
| Q1 2016 | $347,000 | +46.4% | 74,500 | +10.4% | 0.02% | -5.6% |
| Q3 2015 | $237,000 | -82.3% | 67,500 | -14.3% | 0.02% | -71.9% |
| Q1 2014 | $1,342,000 | +633.3% | 78,800 | +333.0% | 0.06% | +300.0% |
| Q3 2013 | $183,000 | +123.2% | 18,200 | +64.0% | 0.02% | +14.3% |
| Q2 2013 | $82,000 | – | 11,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |